Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 289-108-9 | CAS number: 86014-62-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.47 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Dose descriptor starting point:
- NOAEL
- Value:
- 125 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 110.2 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Regarding absorption, in the absence of reliable data for both the starting route (oral) and the end route (inhalation), worst case assumptions were made. It was assumed that a limited absorption occurs by the oral route, leading to a low (conservative) internal NOAEL. To secure a conservative external NOAEL, a maximum absorption should be assumed for the inhalation route (i.e.; 100%) leading to a low external NOAEL. Thus, in the case of oral-to- inhalation extrapolation, it is proposed to include a default factor of 2, i.e. the absorption percentage by oral route is half that of the inhalation absorption as suggested in ECHA Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.8 (2012).
To convert the oral NOAEL into inhalatory NOAEC, a rat default respiratory volume was used corresponding to the daily duration of human exposure (sRVrat: 0.38 m3/kg bw/8 h). For workers a correction was added for the difference between respiratory rates under standard conditions (sRVhuman: 6.7 m3 for an 8 h exposure period) and under conditions of light activity (wRV: 10 m3 for an 8 h exposure period).
The corrected dose descriptor for inhalation is determined using the following equation:
Corrected Inhalatory NOAEC = 1/SRVrat x ABS(oral-rat)/ABS(inh-human) x sRVhuman/wRV
= [125 mg/kg bw/day] X [1/0.38 m3/kg bw/day] X [1/2] X [6.7 m3/10m3].
Thus, the corrected dose descriptor for inhalation is 110.2 mg/m3 for workers.
- AF for dose response relationship:
- 1
- Justification:
- The dose-descriptor is a NOAEL. Table R.8-6 ECHA REACH Guidance.
- AF for differences in duration of exposure:
- 6
- Justification:
- Default factor for a sub-acute study. Table R.8-5 ECHA REACH Guidance.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Table R.8-4 ECHA REACH Guidance. Assessment factor not to be used for inhalation route since the differences in the metabolic rate/bw has already been taken into account in the corrected dose descriptor.
- AF for other interspecies differences:
- 2.5
- Justification:
- Table R.8-4 ECHA REACH Guidance. Assessment factor not to be used for inhalation route since the differences in the metabolic rate/bw has already been taken into account in the corrected dose descriptor.
- AF for intraspecies differences:
- 5
- Justification:
- Default factor for worker. Table R.8-6 ECHA REACH Guidance.
- AF for the quality of the whole database:
- 1
- Justification:
- Default factor for good/standard quality of the database taken into account completeness of the standard information requirements for the tonnage band.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.417 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- NOAEL
- Value:
- 125 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 125 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
For systemic hazard assessment via the dermal route of exposure, route-to-route extrapolation from the oral NOAEL value was considered appropriate. As no data on dermal penetration are available, dermal absorption is considered to be the same as oral absorption (i.e. 100 %). Therefore the oral NOAEL is considered the same as the dermal NOAEL (ECHA Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.8 (2012)).
- AF for dose response relationship:
- 1
- Justification:
- The dose-descriptor is a NOAEL. Table R.8-6 ECHA REACH Guidance.
- AF for differences in duration of exposure:
- 6
- Justification:
- Default factor for a sub-acute study. Table R.8-5 ECHA REACH Guidance.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default allometric scaling factor for rats. Table R.8-4 ECHA REACH Guidance.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default factor for other interspecies differences. Table R.8-6 ECHA REACH Guidance.
- AF for intraspecies differences:
- 5
- Justification:
- Default factor for worker. Table R.8-6 ECHA REACH Guidanc
- AF for the quality of the whole database:
- 1
- Justification:
- Default factor for good/standard quality of the database taken into account completeness of the standard information requirements for the tonnage band.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - workers
For DNEL derivation (long-term systemic for all routes of exposure), the dose descriptor was based on the results of the repeated dose toxicity study where the most sensitive NOAEL of 125 mg/kg bw/day was applied (Dunster et al 2012). Default assessment factors were applied in accordance with ECHA Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.8 (Version 2.1, November 2012).
Long-term systemic hazard assessment for this substance is based on a subacute toxicity study conducted on rats in accordance with OECD 422 under GLP. The substance was administered twice daily to 10 male and 10 female Wistar Han™:RccHan™: rats by oral gavage at dose levels of 60, 125 and 250 mg/kg bw/day for up to eight weeks (including a two week maturation phase, pairing, gestation and early lactation for females). Although there was no recovery phase, this is not a guideline requirement.
The key findings in this study were episodes of increased salivation were evident in animals of either sex treated with 250 mg/kg bw/day and in males treated with 125 mg/kg bw/day during the treatment period. An isolated incident of noisy respiration was also evident in one female treated with 250 mg/kg bw/day on Day 6. No such effects were detected in females treated with 125 mg/kg bw/day or animals of either sex treated with 60 mg/kg bw/day. Males treated with 250 mg/kg bw/day showed a reduction in body weight gain during Weeks 1, 2 and during the final week of treatment. No such effects were detected in females treated with 250 mg/kg bw/day or animals of either sex treated with 125 or 60 mg/kg bw/day. Males treated with 250 mg/kg bw/day showed a slight reduction in overall food consumption when compared to controls. No such effects were detected in females treated with 250 mg/kg bw/day or in animals of either sex treated with 125 or 60 mg/kg bw/day. Sloughing on the non glandular and/or glandular regions of the stomach were evident in a number of animals treated with 250 and 125 mg/kg bw/day and in one male treated with 60 mg/kg bw/day. No such effects were detected in females treated with 60 mg/kg bw/day.
Whilst microscopic changes identified in the stomach may be considered to be adverse, however, they are also considered to be a result of local irritation of the test item rather than a true effect of systemic toxicity. The ‘No Observed Adverse Effect Level’ (NOAEL) for systemic toxicity was therefore considered to be 250 mg/kg bw/day for females and 125 mg/kg bw/day for males.
There was no effects reported for reproductive and developmental toxicology following OECD 422, Dunster J, 2012:
NOAEL (fertility) = 250 mg/kg bw/day
NOAEL (reproduction & development) = 250 mg/kg bw/day
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.362 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 150
- Dose descriptor starting point:
- NOAEL
- Value:
- 125 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 54.35 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Concerning absorption, in the absence of reliable data for both the starting route (oral) and the end route (inhalation), worst case assumptions were made. It was assumed that a limited absorption occurs by the oral route, leading to a low (conservative) internal NOAEL. To secure a conservative external NOAEL, a maximum absorption should be assumed for the inhalation route (i.e.; 100%) leading to a low external NOAEL. Thus, in the case of oral-to- inhalation extrapolation, it is proposed to include a default factor of 2, i.e. the absorption percentage by oral route is half that of the inhalation absorption as suggested in ECHA Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.8 (2012).
To convert the oral NOAEL into inhalatory NOAEC, a rat default respiratory volume was used corresponding to the daily duration of human exposure (sRVrat: 1.15 m3/kg bw/24 h).
The corrected dose descriptor for inhalation is determined using the following equation:
Corrected Inhalator NOAEC = 1/sRVrat x ABSoral-rat/ABSinh-rat x ABSinh-rat/ABSinh-human
= [125 mg/kg bw/day] x [1/1.15 m3/kg bw/ day] x [1/2].
Thus, the corrected dose descriptor for inhalation is 54.35 mg/m3 for the general population.
- AF for dose response relationship:
- 1
- Justification:
- The dose-descriptor is a NOAEL. Table R.8-6 ECHA REACH Guidance.
- AF for differences in duration of exposure:
- 6
- Justification:
- Default factor for a sub-acute. Table R.8-5 ECHA REACH Guidance.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Table R.8-4 ECHA REACH Guidance. Assessment factor not to be used for inhalation route since the differences in metabolic rate/bw has already been taken into account for the corrected dose descriptor.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default factor for other interspecies differences. Table R.8-6 ECHA REACH Guidance.
- AF for intraspecies differences:
- 10
- Justification:
- Default factor for general population. Table R.8-6 ECHA REACH Guidance.
- AF for the quality of the whole database:
- 1
- Justification:
- Default factor for good/standard quality of the database taken into account completeness of the standard information requirements for the tonnage band.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.208 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- NOAEL
- Value:
- 125 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 125 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
For systemic hazard assesment via the dermal route of exposure, route-to-route extrapolation from the oral NOAEL value was considered appropriate. As no data on dermal penetration are available, dermal absorption is considered to be the same as oral absorption (i.e. 100 %). Therefore the oral NOAEL is considered the same as the dermal NOAEL (ECHA Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.8 (2012)).
- AF for dose response relationship:
- 1
- Justification:
- The dose-descriptor is a NOAEL. Table R.8-6 ECHA REACH Guidance.
- AF for differences in duration of exposure:
- 6
- Justification:
- Default factor for a sub-acute study. Table R.8-5 ECHA REACH Guidance.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default allometric scaling factor for rats. Table R.8-4 ECHA REACH Guidance.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default factor for other interspecies differences. Table R.8-6 ECHA REACH Guidance.
- AF for intraspecies differences:
- 10
- Justification:
- Default factor for general population. Table R.8-6 ECHA REACH Guidance.
- AF for the quality of the whole database:
- 1
- Justification:
- Default factor for good/standard quality of the database taken into account completeness of the standard information requirements for the tonnage band.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- Explanation for the modification of the dose descriptor starting point:
An acute dermal study conducted on the substance in accordance with OECD 402 (Anon, 2018) concluded that the substance has a dermal LD50 (females) > 2,000 mg/kg bw. It is therefore concluded that the substance poses no systemic acute dermal hazard.
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.208 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Dose descriptor starting point:
- NOAEL
- Value:
- 125 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 125 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
No modification of the dose descriptor starting point is required. The endpoint used to derive the DNEL uses the oral route for exposure.
- AF for dose response relationship:
- 1
- Justification:
- The dose-descriptor is a NOAEL. Table R.8-6 ECHA REACH Guidance.
- AF for differences in duration of exposure:
- 6
- Justification:
- Default factor for a sub-acute study. Table R.8-5 ECHA REACH Guidance.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default allometric scaling factor for rats. Table R.8-4 ECHA REACH Guidance.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default factor for other interspecies differences. Table R.8-6 ECHA REACH Guidance.
- AF for intraspecies differences:
- 10
- Justification:
- Default factor for good/standard quality of the database taken into account completeness, consistency and the standard information requirements for the tonnage band.
- AF for the quality of the whole database:
- 1
- Justification:
- Default factor for good/standard quality of the database taken into account completeness of the standard information requirements for the tonnage band.
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- low hazard (no threshold derived)
Additional information - General Population
For DNEL derivation (long-term systemic for all routes of exposure), the dose descriptor was based on the results of the repeated dose toxicity study where the most sensitive NOAEL of 125 mg/kg bw/day was applied (Dunster et al 2012). Default assessment factors were applied in accordance with ECHA Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.8 (Version 2.1, November 2012).
Long-term systemic hazard assessment for this substance is based on a subacute toxicity study conducted on rats in accordance with OECD 422 under GLP. The substance was administered twice daily to 10 male and 10 female Wistar Han™:RccHan™: rats by oral gavage at dose levels of 60, 125 and 250 mg/kg bw/day for up to eight weeks (including a two week maturation phase, pairing, gestation and early lactation for females). Although there was no recovery phase, this is not a guideline requirement.
The key findings in this study were episodes of increased salivation were evident in animals of either sex treated with 250 mg/kg bw/day and in males treated with 125 mg/kg bw/day during the treatment period. An isolated incident of noisy respiration was also evident in one female treated with 250 mg/kg bw/day on Day 6. No such effects were detected in females treated with 125 mg/kg bw/day or animals of either sex treated with 60 mg/kg bw/day. Males treated with 250 mg/kg bw/day showed a reduction in body weight gain during Weeks 1, 2 and during the final week of treatment. No such effects were detected in females treated with 250 mg/kg bw/day or animals of either sex treated with 125 or 60 mg/kg bw/day. Males treated with 250 mg/kg bw/day showed a slight reduction in overall food consumption when compared to controls. No such effects were detected in females treated with 250 mg/kg bw/day or in animals of either sex treated with 125 or 60 mg/kg bw/day. Sloughing on the non-glandular and/or glandular regions of the stomach were evident in a number of animals treated with 250 and 125 mg/kg bw/day and in one male treated with 60 mg/kg bw/day. No such effects were detected in females treated with 60 mg/kg bw/day.
Whilst microscopic changes identified in the stomach may be considered to be adverse, however, they are also considered to be a result of local irritation of the test item rather than a true effect of systemic toxicity. The ‘No Observed Adverse Effect Level’ (NOAEL) for systemic toxicity was therefore considered to be 250 mg/kg bw/day for females and 125 mg/kg bw/day for males.
There was no effects reported for reproductive and developmental toxicology following OECD 422, Dunster J, 2012:
NOAEL (fertility) = 250 mg/kg bw/day
NOAEL (reproduction & development) = 250 mg/kg bw/day
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.